Clinical Trials Directory

Trials / Unknown

UnknownNCT02411097

Role of Femoral Nerve Block on Prevention of Postoperative Deep Venous Thromboembolism

Prevention of Deep Venous Thromboembolism: Effect of Preemptive Analgesic of Femoral Nerve Block in Patients Undergoing Total Knee Arthroplasty

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
General Hospital of Ningxia Medical University · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

To investigate whether preemptive analgesic of femoral nerve block could prevent deep venous thromboembolism due to inhibiting the excessive release of neutrophil elastase and inflammatory cytokines.

Detailed description

Femoral nerve block is an effective analgesic mode in patients after total knee arthroplasty. In recent studies, there has been shown that a large amount of neutrophil elastase release from neutrophils could induce the development of deep venous thromboembolism and femoral nerve block may reduce the incidence of the development of deep venous thromboembolism. In addition, inflammatory cytokines including interleukin-1(IL-1), IL-6, IL-8 and tumor necrosis factor(TNF) were associated with deep venous thromboembolism. Thus, the investigators hypothesised that preemptive analgesic of femoral nerve block could prevent deep venous thromboembolism due to inhibiting the excessive release of neutrophil elastase and inflammatory cytokines.

Conditions

Interventions

TypeNameDescription
PROCEDUREfemoral nerve blockuse the nerve stimulator,the femoral nerve block will be administered before or after the surgery

Timeline

Start date
2014-09-01
Primary completion
2015-09-01
Completion
2015-10-01
First posted
2015-04-08
Last updated
2015-04-08

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02411097. Inclusion in this directory is not an endorsement.